Serum uric acid levels are decreased in patients with relapsing-remitting multiple sclerosis, in particular during relapses

被引：0
|
作者：
Tsakiri, Anna [1 ]
Tsiantoulas, Dimitris [2 ]
Frederiksen, Jette [1 ]
机构：
[1] Clin Opt Neuritis, Glostrup, Denmark
[2] Lab Expt Neurol & Neuroimmunol, Thessaloniki, Greece
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S289 / S289
页数：1
相关论文
共 50 条
  • [31] Decreased serum levels of sCD4OL and IL-31 correlate in treated patients with Relapsing-Remitting Multiple Sclerosis
    Guerrero-Garcia, Jose de J.
    Rojas-Mayorquin, Argelia E.
    Valle, Yeminia
    Padilla-Gutierrez, Jorge R.
    Castaneda-Moreno, Victor A.
    Mireles-Ramirez, Mario A.
    Munoz-Valle, Jose F.
    Ortuno-Sahagun, Daniel
    IMMUNOBIOLOGY, 2017, 223 (01) : 135 - 141
  • [32] Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-β
    Balasa, Rodica
    Bajko, Zoltan
    Hutanu, Adina
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (07) : 885 - 890
  • [33] CONCENTRATION OF MAGNESIUM IN THE SERUM AND THE ABILITY STATUS OF PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Karpinska, Elzbieta
    Socha, Katarzyna
    Soroczynska, Jolanta
    Kochanowicz, Jan
    Jakoniuk, Marta
    Mariak, Zenon
    Borawska, Maria H.
    JOURNAL OF ELEMENTOLOGY, 2017, 22 (02): : 671 - 679
  • [34] Differential release of β-chemokines in serum and CSF of patients with relapsing-remitting multiple sclerosis
    Sindern, E
    Niederkinkhaus, Y
    Henschel, M
    Ossege, LM
    Patzold, T
    Malin, JP
    ACTA NEUROLOGICA SCANDINAVICA, 2001, 104 (02): : 88 - 91
  • [35] Serum and cerebrospinal fluid nitrite and nitrate levels in relapsing-remitting and secondary progressive multiple sclerosis patients
    Yuceyar, N
    Taskiran, D
    Sagduyu, A
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2001, 103 (04) : 206 - 211
  • [36] Oxidised low density lipoprotein in serum of relapsing-remitting multiple sclerosis patients
    Sena, A.
    Pedrosa, R.
    Roque, R.
    Tavares, M. A.
    Cascais, M. J.
    Ferret-Sena, V.
    Araujo, C.
    Morais, M. G.
    Couderc, R.
    MULTIPLE SCLEROSIS, 2006, 12 : S168 - S169
  • [37] Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing-Remitting Multiple Sclerosis
    Escribano, Begona M.
    Aguilar-Luque, Macarena
    Bahamonde, Carmen
    Conde, Cristina
    Lillo, Rafael
    Sanchez-Lopez, Fernando
    Giraldo, Ana I.
    Cruz, Antonio H.
    Luque, Evelio
    Gascon, Felix
    Aguera, Eduardo
    Tunez, Isaac
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (31) : 4876 - 4880
  • [38] Serum amyloid A protein is elevated in relapsing-remitting multiple sclerosis
    Ristori, G
    Laurenti, F
    Stacchini, P
    Gasperini, C
    Buttinelli, C
    Pozzilli, C
    Salvetti, M
    JOURNAL OF NEUROIMMUNOLOGY, 1998, 88 (1-2) : 9 - 12
  • [39] Subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis
    Omerzu, Tomaz
    Magdic, Jozef
    Hojs, Radovan
    Potocnik, Uros
    Gorenjak, Mario
    Fabjan, Tanja Hojs
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 136 (1-2) : 40 - 47
  • [40] Screening for dysphagia in patients with relapsing-remitting multiple sclerosis
    Kocica, Jan
    Lasotova, Nadezda
    Kolcava, Jan
    Svobodova, Monika
    Hladikova, Magdalena
    Stourac, Pavel
    Bednarik, Josef
    Vlckova, Eva
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 83
12345